No Detail Found!

Pattern of Coagulopathy and Their Association with Mortality in COVID-19 Patients in Makkah, KSA

Author(s)
IMRAN NAZIR Department of Internal Medicine Security Forces Hospital Makkah,KSA,
SYED MAJID HAMID Internal Medicine Ibrahim Bin Hamad Hospital Ras Alkhaima UAE
ABDUL SHAKOOR Department of Internal Medicine, University Medical & Dental College Faisalabad,Pakistan
RIZWAN RASUL KHAN Department of Internal Medicine, Aziz Fatimah Hospital & Medical College,Faisalabad,Pakistan
MUHAMMAD AJMAL FARID Department of Nephrology, Khamis Mushait hospital,KSA,
IFFAT IMRAN Department of Obstetrics & Gynaecology, College of Medicine Taif University,KSA,
MOHAMMED ALI AL ZUBAIDI Security Forces Hospital,Makkah,
KHALID KHALIL Department of Haemotology, Security Forces Hospital, Makkah, Saudi Arabia
Abstract
Objective: To determine the pattern of coagulation profile and their association with mortality in COVID-19 patients. Study Design: Retrospective descriptive study Place and Duration of Study: Makkah, Saudi Arabia from 2nd March 2020, to 2nd July 2020. Methodology: One thousand, nine hundred and twenty three conceded COVID-19 patients affirmed with polymerase chain response testing were included. Results: Patients' average age was 58.7±2.75 years. Patients drop was observed 6.4% in the survivor group as compared to 0.8% in the non-survivor group with a significant (p=0.000) association with mortality. Prolonged PT/INR was observed in 16% of patients, having a significant association (P=0.003) with mortality. APTT was prolonged in 29.4% of patients, and a comparison of APTT levels between the survivor and non-survivor groups showed a significant difference (p=0.002. A higher fibrinogen level was seen in 23.2% of patients with a significant (p=0.001). Conclusion: Severe COVID-19 infection is related to coagulopathy that is related to the destitute condition of hospitalized patients. Early and consistent evaluation of the coagulation profile along the disease course can help to treat and prevent disease morbidity and mortality in the hospital setting.
Publication Details
Page(s) 337-339
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
COVID-19, COVID-19, Thrombosis, Covid-19, Coagulation profile
References
Barry M,Al Amri M,Memish ZA .2020 .COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health, 10(1) : 1-3.
Huang C,Wang Y,Li X,Ren L .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223) : 497-506.
Guan WJ,Ni ZY,Hu Y .2020 .. Clinical characteristics of coronavirus disease 2019 in China N Engl J Med, 382(18) : 1708-20.
Campbell CM,Kahwash R.,Will R. .2020 .Complement inhibition be the new target in treating COVID-19 related systemic thrombosis. Circulation, 141(22) : 1739-41.
Varga Z,Flammer AJ,Steiger P .2020 .Endothelial cell infection and endotheliitis in. COVID-19. Lancet, 395(10234) : 1417-8.
Kloka FA,Kruipb MJ,van NJN .2020 .Incidence of thrombotic complications in critically ill ICU patients with COVID-19. , : 145-47.
Llitjos JF,Leclerc M,Chochois C .2020 .High incidence of venous thromboembolic events in anticoagulated severe COVID-. patients J Thromb Haemost, 18(7) : 1743-6.
Tang N,Li D,Wang X .2020 .Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18(4) : 844-7.
Cui S,Chen S,Li X .2020 .Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost, 18(6) : 142-24.
Fogarty H,Townsend L,Ni Cheallaigh C .2020 .COVID19 coagulopathy in Caucasian patients. Br J Haematol, 189(6) : 1044-9.
Zhang L,Yan X,Fan Q .2020 .D-dimer levels on admission to predict in-hospital mortality in patients with covid-19. , 18(6) : 1324-9.
Wang T,Chen R,Liu C,Liang W,Guan W,Tang R . .Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.. , : .
.2020 .. Lancet Haematol, 7(5) : e362-3.
Ranucci M,Ballotta A,Di Dedda U .2020 .The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost, 18(7) : 1747-51.
Chen N,Zhou M,Dong X .2020 .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223) : 507-13.
Wang D,Hu B,Hu C .2020 .Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323(11) : 1061-9.
Zhou F,Yu T,Du R .2020 .Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395(10229) : 1054-62.
Sandersjoo AF,Bellanderab BM .2020 .Is COVID-19 associated thrombosis caused by over activation of the complement cascade? A literature review. Thrombosis Res, (194 : 36-41.
Tang N,Li D,Wang X .2020 .Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18(4) : 844-7.
.2020 .Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system. Italy. Euro Surveill, 25(19) : 2000620.
Petrilli CM,Jones SA,Yang J . .Factors associated with hospitalization and critical illness among 4103 patients with COVID-19. , : .
.2020 .. Med Rxiv, : .
Libby P,Lüscher T .2020 .-19 is, in the end, an endothelial disease. Eur Heart J, 41(32) : 3038-44.
Iba T,Levy JH,Warkentin TE .2020 .. The unique characteristics of COVID-19 coagulopathy. Critical Care, : 360.
Hoshino K,Kitamura T,Nakamura Y .2017 .Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis. J Intensive Care, 5 : 42.
Taylor FB ,Toh CH,Hoots WK .2001 .Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost, 86(5) : 1327-30.
Levi M,Toh CH,Thachil J .2009 .Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol, 145(1) : 24-33.
RL Bick .2002 .Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost, 8(1) : 1-31.
Gao Y,Li T,Han M .2020 .Diagnostic utility of clinical laboratory data determinations for patients with the severe. COVID-19. J Med Virol, 92(7) : 791-6.
Connors JM,Levy JH .2020 .COVID-19 and its implications for thrombosis and anticoagulation. Blood, 135(23) : 2033-40.
Wu C,Chen X,Cai Y .2020 .Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med, 180(7) : 934-43.
Lippi G,Plebani M,Henry BM .2020 .Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta, 506 : 145-8.
Panigada M,Bottino N,Tagliabue P .2020 .Hypercoagulability of COVID-19 patients in intensive care unit. a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost, 18(7) : 1738-42.
Spiezia L,Boscolo A,Poletto F .2020 .-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost, 120(6) : 998-1000.
Thachil J. .2020 .All those D-dimers in. COVID-19. J Thromb Haemost, 18(8) : 2075-6.
0

Citations

0

Downloads

73

Views